Serna Ángel, Navarro V, Iacoboni G, López L, Sancho J-M, González-Barca E, López-García A, Córdoba R, Sáez A, Ubieto AJ, Ferrero A, García T, Sánchez Ángela, García C, Bosch M, Cabirta A, Jiménez M, Marín-Niebla A, Bosch F, Abrisqueta P. Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes. haematol [Internet]. 2020Sep.10 [cited 2024Jul.18];. Available from: https://haematologica.org/article/view/haematol.2024.285219